David Portnoy, Chairman of the Board and Co-CEO, stated, “After several months of careful evaluation of the results from the early-stage clinical trials conducted by Duke University, Cryo-Cell ...

Umbilical cord blood banking is useful due to its role in transplantation. Hematopoietic stem cells (HSCs) possess the ability to reconstitute any blood cell type, offering the potential to treat ...

Umbilical cord and placenta blood, often referred to as “cord blood,” is the blood that is collected from the umbilical and placental tissue at birth. Once stored in “banks,” its stem cells can be ...

With a record of more than 2,300 successful transplants, StemCyte has become one of the most experienced providers in the field. The company upholds rigorous standards -- FACT and AABB accreditations, ...

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, ...

Before you got pregnant, you may not have given umbilical cords much thought. But did you know it's full of cells that could save someone's life? Not to brag, but cord blood is a pretty big deal, and ...

Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first ...

OLDSMAR, Fla.--(BUSINESS WIRE)-- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, ...

DURHAM – A Florida-based publicly-traded company that describes itself as the country’s “first private cord blood bank” may soon open a Durham facility. The company, Cryo-Cell International, disclosed ...

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, ...

The Company reported net income for the three months ended August 31, 2025 of $749,000, or $0.09 per basic share and diluted share, compared to net income of $1.05 million, or $0.13 per basic and ...

Consolidated revenues for the third quarter of fiscal 2025 were $7.83 million compared to $8.07 million for the third quarter of fiscal 2024, a 3% decrease. The Company reported net income for the ...